Revance Therapeutics | 4:持股变动声明-董事 Ware Olivia C
Revance Therapeutics | 4:持股变动声明-董事 Russell Angus C.
Revance Therapeutics | 4:持股变动声明-董事 Nolet Chris
Revance Therapeutics | 4:持股变动声明-董事 Kolaja Carey OConnor
Revance Therapeutics | 4:持股变动声明-董事 Gangolli Julian S
Revance Therapeutics | 4:持股变动声明-董事 Coric Vlad
Revance Therapeutics | 4:持股变动声明-董事 Beraud Jill
Revance Therapeutics | 4:持股变动声明-高管 Jordan Erica
Revance Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-JPMORGAN CHASE & CO.(2.6%)
Revance Therapeutics | 4:持股变动声明-高管 Sjuts Dustin S
Revance Therapeutics | 4:持股变动声明-高管 Moxie Dwight
Revance Therapeutics | 4:持股变动声明-高管 Schilke Tobin
Revance Therapeutics | 4:持股变动声明-高管 Foley Mark J
Revance Therapeutics | 4:持股变动声明-高管 Foley Mark J
Revance Therapeutics | 4:持股变动声明-高管 Sjuts Dustin S
Revance Therapeutics | 4:持股变动声明-高管 Moxie Dwight
Revance Therapeutics | 4:持股变动声明-高管 Schilke Tobin
Revance Therapeutics | 4:持股变动声明-高管 Foley Mark J
Revance Therapeutics | 3:首次持股声明-高管 Jordan Erica
Revance Therapeutics | 3:首次持股声明-高管 Hollander David
暂无数据